ADJUVANT, PVAX14 DNA, AS AN IMMUNOTHERAPY FOR A MOUSE MODEL OF HIGH RISK MYELODYSPLASTIC SYNDROME (HR-MDS) EXTENDS SURVIVAL AS ADD-ON TREATMENT TO AZACITIDINE (AZA)R. A. Padua,P. Gorombei,C. Le Pogam,S. Patel,L. Guerenne,N. Omidvar, R. R. West,M. Pla,P. Krief, P. Fenaux,C. ChomienneLeukemia Research（2015）引用 0|浏览28暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
